Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Verge HealthTech Fund does not develop drugs or devices directly but invests in early-stage healthtech startups globally. Its portfolio companies span digital therapeutics, diagnostics, AI-enabled platforms, and digital health solutions. Several portfolio companies have advanced from pre-regulatory to early revenue stages.
Example clinical progress of portfolio:
The fund has invested in over 52 startups across more than 21 countries impacting over 60 million lives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Verge HealthTech Fund.